The smoke-free home study: study protocol for a cluster randomized controlled trial of a smoke-free home intervention in permanent supportive housing.
Community-based
Homeless
Permanent supportive housing
Smoke-free home
Smoking
Tobacco
Tobacco-cessation
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
14 11 2022
14 11 2022
Historique:
received:
27
09
2022
accepted:
23
10
2022
entrez:
15
11
2022
pubmed:
16
11
2022
medline:
18
11
2022
Statut:
epublish
Résumé
Formerly chronically homeless adults who live in permanent supportive housing (PSH) have high prevalence of smoking. It is uncommon to find smoke-free policies in PSH because of the concern that such policies contradict PSH's harm reduction framework and could increase homelessness should residents lose their housing because of the policy. However, in the absence of such policies, non-smoking PSH residents face the harmful effects of secondhand smoke exposure while residents who smoke see increased risks from high rates of smoking throughout their residence. Our pilot work highlighted the feasibility and acceptability of an intervention designed to promote voluntary adoption of a smoke-free home. Here we report a protocol for a cluster randomized controlled trial of the smoke-free home intervention for formerly chronically homeless residents in PSH. The smoke-free home intervention provides face-to-face counseling and instruction to PSH residents on how to adopt a smoke-free home and offers training for PSH staff on how to refer residents to tobacco cessation services. We will randomize 20 PSH sites in the San Francisco Bay Area to either the intervention or wait-list control arms. We will enroll 400 PSH residents who smoke cigarettes in their housing unit and 120 PSH staff who work at the sites. At baseline, three- and six-months follow-up, we will ask residents to report their tobacco use and cessation behaviors and adoption of smoke-free homes. We will ask staff to answer questions on their knowledge, attitudes, practices, and barriers related to supporting residents' smoking cessation. The primary outcome for PSH residents is adoption of smoke-free homes for 90 days or more at six-months follow-up, and the secondary outcome is point prevalence tobacco abstinence. The primary outcome for PSH staff is change in Smoking Knowledge Attitudes Practices survey score. Voluntary adoption of smoke-free homes is a promising approach for reducing exposure to secondhand smoke and reducing tobacco use among a population facing high rates of tobacco-related disease, and is aligned with PSH's harm reduction framework. Findings from this study have the potential to inform adoption of tobacco control policies among vulnerable populations most at risk for smoking-related harms. This study was registered with the U.S. National Institute of Health Clinical Trials register on April 22, 2021: NCT04855357.
Sections du résumé
BACKGROUND
Formerly chronically homeless adults who live in permanent supportive housing (PSH) have high prevalence of smoking. It is uncommon to find smoke-free policies in PSH because of the concern that such policies contradict PSH's harm reduction framework and could increase homelessness should residents lose their housing because of the policy. However, in the absence of such policies, non-smoking PSH residents face the harmful effects of secondhand smoke exposure while residents who smoke see increased risks from high rates of smoking throughout their residence. Our pilot work highlighted the feasibility and acceptability of an intervention designed to promote voluntary adoption of a smoke-free home. Here we report a protocol for a cluster randomized controlled trial of the smoke-free home intervention for formerly chronically homeless residents in PSH.
METHODS
The smoke-free home intervention provides face-to-face counseling and instruction to PSH residents on how to adopt a smoke-free home and offers training for PSH staff on how to refer residents to tobacco cessation services. We will randomize 20 PSH sites in the San Francisco Bay Area to either the intervention or wait-list control arms. We will enroll 400 PSH residents who smoke cigarettes in their housing unit and 120 PSH staff who work at the sites. At baseline, three- and six-months follow-up, we will ask residents to report their tobacco use and cessation behaviors and adoption of smoke-free homes. We will ask staff to answer questions on their knowledge, attitudes, practices, and barriers related to supporting residents' smoking cessation. The primary outcome for PSH residents is adoption of smoke-free homes for 90 days or more at six-months follow-up, and the secondary outcome is point prevalence tobacco abstinence. The primary outcome for PSH staff is change in Smoking Knowledge Attitudes Practices survey score.
DISCUSSION
Voluntary adoption of smoke-free homes is a promising approach for reducing exposure to secondhand smoke and reducing tobacco use among a population facing high rates of tobacco-related disease, and is aligned with PSH's harm reduction framework. Findings from this study have the potential to inform adoption of tobacco control policies among vulnerable populations most at risk for smoking-related harms.
TRIAL REGISTRATION
This study was registered with the U.S. National Institute of Health Clinical Trials register on April 22, 2021: NCT04855357.
Identifiants
pubmed: 36376812
doi: 10.1186/s12889-022-14423-y
pii: 10.1186/s12889-022-14423-y
pmc: PMC9664594
doi:
Substances chimiques
Tobacco Smoke Pollution
0
Banques de données
ClinicalTrials.gov
['NCT04855357']
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2076Subventions
Organisme : NCI NIH HHS
ID : R37 CA248448
Pays : United States
Informations de copyright
© 2022. The Author(s).
Références
AIDS Behav. 2014 Mar;18(3):535-43
pubmed: 23918243
Nicotine Tob Res. 2006 Oct;8(5):661-9
pubmed: 17008193
Am J Public Health. 2015 Mar;105(3):530-7
pubmed: 25602863
J Gen Intern Med. 2006 Aug;21(8):867-73
pubmed: 16881949
Psychiatr Serv. 2005 Jan;56(1):63-9
pubmed: 15637194
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
N Engl J Med. 2010 Jun 17;362(24):2319-25
pubmed: 20554988
Int J Environ Res Public Health. 2021 Nov 29;18(23):
pubmed: 34886292
AMA J Ethics. 2017 Sep 1;19(9):862-872
pubmed: 28905727
J Community Health. 2016 Oct;41(5):998-1005
pubmed: 26983929
Am J Health Promot. 2020 Jan;34(1):32-41
pubmed: 31537083
Nicotine Tob Res. 2013 Jul;15(7):1316-21
pubmed: 23248030
Drug Alcohol Depend. 2010 Jul 1;110(1-2):137-43
pubmed: 20347232
J Epidemiol Community Health. 2022 Jun 14;:
pubmed: 35701105
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Drug Alcohol Rev. 2005 May;24(3):217-26
pubmed: 16096125
Int J Environ Res Public Health. 2022 Mar 05;19(5):
pubmed: 35270744
BMC Public Health. 2015 Dec 04;15:1209
pubmed: 26634243
Stat Med. 1998 Oct 15;17(19):2265-81
pubmed: 9802183
Implement Sci. 2017 Nov 14;12(1):134
pubmed: 29137666
JAMA Netw Open. 2020 Nov 2;3(11):e2024385
pubmed: 33151318
Int J Geriatr Psychiatry. 2011 Sep;26(9):881-5
pubmed: 20661878
J Gen Intern Med. 2016 Oct;31(10):1206-11
pubmed: 27170304
Am J Public Health. 2013 Dec;103(12):2276-83
pubmed: 24134354
Drug Alcohol Depend. 2014 Oct 1;143:263-7
pubmed: 25107312
Public Health Rep. 2020 Jul/Aug;135(4):415-419
pubmed: 32353245
Nicotine Tob Res. 2021 Jan 7;23(1):63-70
pubmed: 32123908
Health Serv Res. 2002 Jun;37(3):733-50
pubmed: 12132603
Addiction. 2008 Jun;103(6):1039-47
pubmed: 18373724
PLoS One. 2018 Jul 27;13(7):e0201467
pubmed: 30052671
CA Cancer J Clin. 2020 Jan;70(1):31-46
pubmed: 31661164
Implement Sci. 2016 May 18;11(1):73
pubmed: 27193580
Am J Public Health. 2004 Mar;94(3):416-22
pubmed: 14998805
J Health Psychol. 1997 Jul;2(3):335-51
pubmed: 22013026
JAMA Intern Med. 2013 Feb 11;173(3):235-7
pubmed: 23319013
Cancer. 2014 Jul 1;120(13):1914-6
pubmed: 24687615
J Community Health. 2018 Apr;43(2):312-320
pubmed: 28884243
Am J Prev Med. 2018 Feb;54(2):320-322
pubmed: 29246676
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Nicotine Tob Res. 2002 May;4(2):149-59
pubmed: 12028847
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Addiction. 2002 Sep;97(9):1183-94
pubmed: 12199834
J Drug Issues. 2009 Mar;39(2):347-364
pubmed: 20717496
Am J Prev Med. 1994 Mar-Apr;10(2):77-84
pubmed: 8037935
Health Promot Pract. 2020 Nov;21(6):972-982
pubmed: 30971139
Am J Public Health. 2004 Apr;94(4):651-6
pubmed: 15054020
N Engl J Med. 2013 Jul 18;369(3):201-4
pubmed: 23863048